Sectors
ALT
Altimmune, Inc.
2.81
6 x 2.80
19 x 2.81
bid
ask
-
0.01
0.53%
11:14 AM
timesize
| Ytd | -22.30% | |
| 1y | -33.21% |
2.79
day range
2.87
2.56
52 week range
6.44
| Open | 2.81 | Prev Close | 2.82 | Low | 2.79 | High | 2.87 | Mkt Cap | 248.89M |
| Vol | 534.45K | Avg Vol | 4.40M | EPS | -0.93 | P/E | -3.03 | Forward P/E | -5.14 |
| Beta | 0.25 | Short Ratio | 5.81 | Inst. Own | 56.68% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 01-20 | Earning | 08-11 | 50-d Avg | 2.90 | 200-d Avg | 3.81 | 1yr Est | 22.86 |
| Income Statement | |||
| Operating Expenses | 24.24M | ||
| Research and Development Expense | 16.19M | ||
| Selling, General and Administrative Expense | 8.05M | ||
| Operating Income | -24.24M | ||
| Interest Expense | 1.07M | ||
| Net Income | -22.56M | ||
| Net Income Common Stock | -22.56M | ||
| Net Income Common Stock (USD) | -22.56M | ||
| Consolidated Income | -22.56M | ||
| Earnings per Basic Share | -0.18 | ||
| Earnings per Basic Share (USD) | -0.18 | ||
| Earnings per Diluted Share | -0.18 | ||
| Earning Before Interest & Taxes (EBIT) | -21.49M | ||
| Earning Before Interest & Taxes (USD) | -21.49M | ||
| Weighted Average Shares | 124.46M | ||
| Weighted Average Shares Diluted | 124.46M | ||
| Balance Sheet | |||
| Cash and Equivalents | 97.64M | ||
| Cash and Equivalents (USD) | 97.64M | ||
| Investments | 233.94M | ||
| Investments Current | 233.94M | ||
| Trade and Non-Trade Receivables | 1.67M | ||
| Current Assets | 334.68M | ||
| Property, Plant & Equipment Net | 208.00K | ||
| Total Assets | 335.63M | ||
| Total Debt | 34.51M | ||
| Current Liabilities | 11.32M | ||
| Debt Non-Current | 34.51M | ||
| Total Liabilities | 51.64M | ||
| Accumulated Retained Earnings (Deficit) | -672.05M | ||
| Accumulated Other Comprehensive Income | -5.22M | ||
| Shareholders Equity | 283.99M | ||
| Shareholders Equity (USD) | 283.99M | ||
| Assets Non-Current | 954.00K | ||
| Total Debt (USD) | 34.51M | ||
| Liabilities Non-Current | 40.32M | ||
| Trade and Non-Trade Payables | 1.53M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 23.00K | ||
| Net Cash Flow from Financing | 78.47M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 53.84M | ||
| Capital Expenditure | -21.00K | ||
| Issuance (Purchase) of Equity Shares | 79.26M | ||
| Net Cash Flow from Investing | -3.69M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -3.67M | ||
| Net Cash Flow from Operations | -20.94M | ||
| Share Based Compensation | 3.38M | ||